Revelation Biosciences In... (REVB)

3.51

-0.03 (-0.85%)

At close: Feb 28, 2025, 3:59 PM

3.33

-5.14%

After-hours: Feb 28, 2025, 04:59 PM EST

Revelation Biosciences Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-120.25K	-10.83M	-11.99M	-1.63M	-3.64K
Depreciation & Amortization	25.05K	25.05K	16.78K	n/a	n/a
Stock-Based Compensation	155.72K	301.12K	470.88K	43.85K	n/a
Other Working Capital	232.47K	-64.93K	625.86K	-80.5K	3.64K
Other Non-Cash Items	-8.33M	14.96K	52.38K	1.5M	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	982.13K	-730.97K	356.22K	-80.5K	3.64K
Operating Cash Flow	-7.29M	-11.22M	-11.09M	-215.07K	n/a
Capital Expenditures	-4	n/a	-131.96K	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	-74.04M	n/a
Sales Maturities Of Investments	n/a	n/a	525.29K	n/a	n/a
Other Investing Acitivies	n/a	n/a	-525.29K	-74.04M	n/a
Investing Cash Flow	n/a	n/a	-131.96K	-74.04M	n/a
Debt Repayment	n/a	-796.88K	n/a	15K	n/a
Common Stock Repurchased	-5K	-7.65M	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-4.97K	11.54M	7.4M	-65.4M	10K
Financial Cash Flow	14.03M	15.2M	8M	74.26M	n/a
Net Cash Flow	6.74M	3.98M	-3.22M	-74.23M	n/a
Free Cash Flow	-7.29M	-11.22M	-11.22M	-215.07K	n/a